BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) released its quarterly earnings results on Friday. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.05, FiscalAI reports. The business had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.66 billion. BrightSpring Health Services had a return on equity of 14.63% and a net margin of 2.27%.BrightSpring Health Services’s revenue for the quarter was up 23.0% on a year-over-year basis. During the same quarter last year, the company posted $0.22 EPS.
Here are the key takeaways from BrightSpring Health Services’ conference call:
- BrightSpring reported a strong second quarter, with revenue of $3.9 billion, up 23% year over year, and adjusted EBITDA of $206 million, up 44%, while EBITDA margin expanded 80 basis points to 5.3%.
- Specialty and infusion pharmacy revenue increased 30%, supported by 31% script growth and continued momentum in limited-distribution drugs; the company added two ultranarrow-network drugs, bringing its LDD portfolio to 155.
- Provider Services grew 30%, led by home health revenue growth of 51% and contributions from the Amedisys and LHC branches. BrightSpring raised its expected 2026 EBITDA contribution from those acquired assets to approximately $35 million.
- The Inflation Reduction Act is expected to reduce 2026 home and community pharmacy revenue by approximately $200 million, including about $45 million in each remaining quarter; management estimates the 2027 impact will be roughly half as large.
- BrightSpring reduced leverage to 2.15x, repaid approximately $300 million of term debt, refinanced at a 50-basis-point lower spread, and received credit-rating upgrades. Management now expects about $600 million of 2026 operating cash flow and year-end leverage below 2x before acquisitions, supporting additional M&A flexibility.
BrightSpring Health Services Stock Down 18.1%
BrightSpring Health Services stock traded down $13.17 during mid-day trading on Friday, hitting $59.71. The company’s stock had a trading volume of 7,726,295 shares, compared to its average volume of 3,028,156. BrightSpring Health Services has a 52-week low of $19.01 and a 52-week high of $73.75. The company has a market cap of $11.78 billion, a PE ratio of 42.35, a price-to-earnings-growth ratio of 0.88 and a beta of 1.79. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.74 and a quick ratio of 1.38. The firm’s 50 day moving average is $66.35 and its 200 day moving average is $51.80.
Trending Headlines about BrightSpring Health Services
- Positive Sentiment: BrightSpring reported second-quarter adjusted earnings of $0.45 per share, above analyst estimates of $0.40 and up from $0.22 a year earlier. Revenue rose 23% year over year to $3.87 billion, exceeding the $3.66 billion consensus estimate. BrightSpring Health Services Q2 earnings report
- Positive Sentiment: The company increased its full-year 2026 revenue guidance to $15.1 billion-$15.4 billion, with the low end roughly in line with consensus and the upper end above expectations. Management also projected adjusted EBITDA of $820 million-$845 million and is targeting leverage below 2x, which could support debt reduction and financial flexibility. BrightSpring Q2 2026 results and guidance
- Neutral Sentiment: The earnings call and analyst coverage emphasized that both revenue and profit surpassed expectations, but the company did not provide a notable full-year EPS guidance figure in the available reports. BrightSpring Q2 2026 earnings call transcript
- Negative Sentiment: The revenue outlook appears only modestly ahead of Wall Street expectations, which may have disappointed investors seeking a larger guidance increase. With BTSG trading at a relatively elevated earnings multiple after reaching a 52-week high, the strong quarter may have been insufficient to meet elevated expectations, triggering selling despite the earnings and revenue beats.
Insider Activity
In other news, insider Jon B. Rousseau sold 130,000 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $58.75, for a total value of $7,637,500.00. Following the completion of the sale, the insider directly owned 1,194,503 shares of the company’s stock, valued at $70,177,051.25. This represents a 9.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Lisa A. Nalley sold 35,000 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $58.75, for a total transaction of $2,056,250.00. Following the sale, the insider owned 131,948 shares of the company’s stock, valued at approximately $7,751,945. This represents a 20.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 2.80% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in BTSG. Arrowstreet Capital Limited Partnership boosted its stake in shares of BrightSpring Health Services by 216.6% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 320,134 shares of the company’s stock valued at $9,463,000 after buying an additional 219,005 shares during the period. ExodusPoint Capital Management LP increased its stake in shares of BrightSpring Health Services by 248.3% in the fourth quarter. ExodusPoint Capital Management LP now owns 95,431 shares of the company’s stock worth $3,574,000 after acquiring an additional 68,031 shares during the last quarter. California State Teachers Retirement System raised its holdings in shares of BrightSpring Health Services by 1.7% during the fourth quarter. California State Teachers Retirement System now owns 92,605 shares of the company’s stock worth $3,468,000 after acquiring an additional 1,577 shares in the last quarter. Counterpoint Mutual Funds LLC purchased a new stake in shares of BrightSpring Health Services during the fourth quarter worth $3,367,000. Finally, MetLife Investment Management LLC boosted its position in BrightSpring Health Services by 12.0% during the fourth quarter. MetLife Investment Management LLC now owns 61,489 shares of the company’s stock valued at $2,303,000 after purchasing an additional 6,592 shares during the last quarter.
Analysts Set New Price Targets
A number of research firms have commented on BTSG. Wells Fargo & Company upped their price objective on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the company an “overweight” rating in a research note on Monday, July 13th. KeyCorp lifted their target price on shares of BrightSpring Health Services from $60.00 to $80.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. BTIG Research boosted their price target on shares of BrightSpring Health Services from $65.00 to $90.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Raymond James Financial started coverage on shares of BrightSpring Health Services in a research report on Thursday, July 9th. They issued an “outperform” rating and a $80.00 price target for the company. Finally, TD Cowen raised their price objective on shares of BrightSpring Health Services from $65.00 to $81.00 and gave the stock a “buy” rating in a research note on Thursday, June 18th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $70.12.
Get Our Latest Analysis on BrightSpring Health Services
BrightSpring Health Services Company Profile
BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.
Further Reading
- Five stocks we like better than BrightSpring Health Services
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
